Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

06/20/09 Very late relapses in glioblastoma long-term survivors.        

06/20/09 A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.        

06/20/09 Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma.        

06/20/09 Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab (Avastin)        

06/12/09 Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.        

06/12/09 Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma        

06/12/09 UPDATE 1-Exelixis brain cancer drug response rates lowered        

06/12/09 Norton launches new brain-tumor program        

06/12/09 Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program        

06/10/09 Suppressing Glioblastoma Stem Cell Function by Aldehyde Dehydrogenase Inhibition with Chloramphenicol or Disulfiram as a New Treatment Adjunct: An Hypothesis.        

06/02/09 David Bailey will perform at 7pm on Saturday, June 6th in Hercules, CA (which is near Berkeley, CA)        

06/02/09 New videos added to the Virtualtrials.com video library!        

06/01/09 Al Musella (President Of the Musella Foundation) to receive "Voices" award on Thursday, June 4th in NYC!        

06/01/09 TransMolecular Presents New Data Highlighting the Anti-angiogenic and Tumor-targeting Properties of TM601 at ASCO Annual Meeting        

06/01/09 Drug Made From Cottonseed May Slow Brain Cancer, Researchers Say        

06/01/09 Most common brain cancer may originate in neural stem cells        

06/01/09 Pfizer and Celldex Therapeutics Present Update on CDX-110 (PF-04948568) Phase 2 Brain Cancer Studies at 45th Annual ASCO Meeting        

05/28/09 Common Cancer Drug (Avastin) May Increase Risk of Deadly GI Perforations        

05/28/09 Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program        

---

Displaying Stories 3181 to 3200 of 7673
Previous 20           Next 20